User Tools

Site Tools


Randomized controlled trial

(or randomised control trial; RCT) is a type of scientific (often medical) experiment, where the people being studied are randomly allocated one or other of the different treatments under study. The RCT is the gold standard for a clinical trial. RCTs are often used to test the efficacy or effectiveness of various types of medical intervention and may provide information about adverse effects, such as drug reactions. Random assignment of intervention is done after subjects have been assessed for eligibility and recruited, but before the intervention to be studied begins.

Experimental study designs can provide the evidence needed to answer pertinent clinical questions. To study the efficacy of a treatment, there needs to be a control group, ideally in the context of a randomized controlled trial (RCT).

Although the call for evidence based practice in surgery is increasingly high on the agenda, most surgeons feel that the format of the randomized controlled trial is not suitable for surgery 1) 2).

Random allocation in real trials is complex, but conceptually, the process is like tossing a coin. After randomization, the two (or more) groups of subjects are followed in exactly the same way, and the only differences between the care they receive, for example, in terms of procedures, tests, outpatient visits, and follow-up calls, should be those intrinsic to the treatments being compared. The most important advantage of proper randomization is that it minimizes allocation bias, balancing both known and unknown prognostic factors, in the assignment of treatments.

The terms “RCT” and randomized trial are sometimes used synonymously, but the methodologically sound practice is to reserve the “RCT” name only for trials that contain control groups, in which groups receiving the experimental treatment are compared with control groups receiving no treatment (a placebo-controlled study) or a previously tested treatment (a positive-control study). The term “randomized trials” omits mention of controls and can describe studies that compare multiple treatment groups with each other (in the absence of a control group).

Similarly, although the “RCT” name is sometimes expanded as “randomized clinical trial” or “randomized comparative trial”, the methodologically sound practice, to avoid ambiguity in the scientific literature, is to retain “control” in the definition of “RCT” and thus reserve that name only for trials that contain controls. Not all randomized clinical trials are randomized controlled trials (and some of them could never be, in cases where controls would be impractical or unethical to institute). The term randomized controlled clinical trials is a methodologically sound alternate expansion for “RCT” in RCTs that concern clinical research; however, RCTs are also employed in other research areas, including many of the social sciences.


Phase 1 randomized controlled trial

Phase 2 randomized controlled trial

Phase 3 randomized controlled trial

Phase IV: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

A study aimed to determine the trial discontinuation and publication rate of randomized controlled trials (RCTs) in neurosurgery.

Trials registered from 2000 to 2012 were identified on the website using a range of key words related to neurosurgery. Any trials that were actively recruiting or had unknown status were excluded. Included trials were assessed for whether they were discontinued early on the database; this included trials identified as withdrawn, suspended, or terminated in the database. For included trials, a range of parameters was identified including the subspecialty, primary country, study start date, type of intervention, number of centers, and funding status. Subsequently, a systematic search for published peer-reviewed articles was undertaken. For trials that were discontinued early or were found to be unpublished, principal investigators were sent a querying email.

Sixty-four neurosurgical trials fulfilled our inclusion criteria. Of these 64, 26.6% were discontinued early, with slow or insufficient recruitment cited as the major reason (57%). Of the 47 completed trials, 14 (30%) remained unpublished. Discontinued trials showed a statistically significant higher chance of remaining unpublished (88%) compared with completed trials (p = 0.0002). Industry-funded trials had a higher discontinuation rate (31%) compared with non-industry-funded trials (23%), but this result did not reach significance (p = 0.57). Reporting of primary outcome measures was complete in 20 (61%) of 33 trials. For secondary outcome measures, complete reporting occurred in only 11 (33.3%) of 33.

More than a fifth (26.6%) of neurosurgical RCTs are discontinued early and almost a third of those that are completed remain unpublished. This result highlights significant waste of financial resources and clinical data 3).

Unger CA, Barber MD. Studying surgical innovations: challenges of the randomized controlled trial. J Minim Invasive Gynecol 2015;22:573–82.
Ceelen WP. Clinical research in surgery: threats and opportunities. Eur Surg Res 2014;53:95–107.
Jamjoom AAB, Gane AB, Demetriades AK. Randomized controlled trials in neurosurgery: an observational analysis of trial discontinuation and publication outcome. J Neurosurg. 2017 Oct;127(4):857-866. doi: 10.3171/2016.8.JNS16765. Epub 2016 Nov 25. PubMed PMID: 27885950.
randomized_controlled_trial.txt · Last modified: 2017/11/13 08:56 by administrador